News
Mannatech Announces Final Results of Tender Offer
Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced today the final results
Mannatech Announces Results of Annual Shareholders’ Meeting
Mannatech, Incorporated (Nasdaq: MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all
Genprex Added to Russell 3000® Index
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Mannatech Announces Preliminary Results of Tender Offer
Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced today the preliminary
Genprex Receives USAN Approval of Non-Proprietary Name for Lead Drug Candidate
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Genprex CEO to Interview Live on “The Big Biz Show”
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
1347 Property Insurance Holdings, Inc. Appoints Larry Swets as Interim Chief Executive Officer to Lead Organization Through Formative Stages of Launching Its Diversified Holding Company Strategy
1347 Property Insurance Holdings, Inc. (Nasdaq: PIH) (the “Company”) announced today that it has appointed current Board Member and Former Chairman Larry G. Swets Jr. as its Interim Chief Executive
Genprex Expands Manufacturing Program with Aldevron to Advance Oncoprex™ Clinical Development
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced
Dragon Victory International Limited Receives Nasdaq Staff Deficiency Letter
Dragon Victory International Limited (Nasdaq: LYL) (the “Company”), a company offering reward-based crowdfunding opportunities and quality incubation services to entrepreneurs in China, announced
Genprex Scheduled to Join Russell 3000® Index
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Genprex to Present at the MoneyShow June Virtual Event
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced
Nashville Superspeedway to Host the NASCAR Cup Series in 2021
NASCAR and Dover Motorsports, Inc. (NYSE: DVD) have agreed to host a NASCAR Cup Series race at Nashville Superspeedway in 2021.
“We were energized to see how excited Nashville was to host the
Next Gen Bango Technology Grows Active Customers for du
Bango (AIM: BGO), the mobile commerce company, announces that deploying its payment optimization technology has enabled du, the leading UAE mobile operator, to grow its active carrier billing
Digirad Celebrates the 20th Anniversary of the First Commercially Performed Solid-state Nuclear Medicine Scan
Digirad, a leading provider of nuclear imaging and diagnostic expertise, is celebrating the 20th anniversary of the first commercially performed solid-state nuclear medicine image being scanned
Novus Therapeutics Announces Topline Results of Phase 2a Clinical Trial of OP0201 in Acute Otitis Media
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, today announced topline results
Mannatech Commences Cash Tender Offer to Purchase up to $5 Million of Its Common Stock
Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announces today it has commenced
Wirecard: Fallen die 100 Euro schon nächste Woche?
Während die meisten Börsenmedien nichts Besseres zu tun haben, als mit dem Strom zu schwimmen und Kursen hinterherzuplappern, lagen wir mit unseren Wirecard-Ansagen zuletzt goldrichtig. Auch unsere
Sonoma Pharmaceuticals: NBC-Empfehlung mit +150% in 7 Stunden
Was für eine Bombe: Sonoma Pharmaceuticals (WKN: A2PMPH) meldet nachbörslich die offizielle Zulassung seines Desinfektionsmittels gegen die Covid-19-Erkrankung durch die australische
Sonoma: „Durchbruch im Kampf gegen die globale Coronavirus-Pandemie“
Was für eine Bombe: Sonoma Pharmaceuticals (WKN: A2PMPH) meldet nachbörslich die offizielle Zulassung seines Desinfektionsmittels gegen die Covid-19-Erkrankung durch die australische
Mannatech Announces Intent to Commence a Cash Tender Offer to Purchase up to $5 Million of Its Common Stock
Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, intends to conduct a modified
DropCar and AYRO Stockholders Approve Merger
DropCar, Inc. (“DropCar”) (NASDAQ: DCAR) and AYRO, Inc. (“AYRO”) today announced that at DropCar’s special meeting of stockholders held on May 27, 2020, DropCar obtained sufficient votes for each
Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced
Mannatech Declares First Quarter 2020 Dividend
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend
Sonoma Pharmaceuticals: Offizielle Covid-19-Zulassung!
Auffällige Käufe bei Sonoma Pharmaceuticals (WKN: A2PMPH): SD-Leser sind dem Markt erneut voraus und wissen um die Hintergründe. Diese eröffnen enorme Kursphantasie
In einer aktuellen
Novus Therapeutics Reports First Quarter 2020 Financial Results
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, today announced financial